“Lipohypertrophy at Injection Sites: An Underexamined Cause of Unexplained Glycaemic Variability”. Journal of Clinical Diabetes and Obesity, vol. 6, no. 1, Aug. 2026, pp. 43-48, https://doi.org/10.5281/zenodo.22261640.